RxDoctor Payments Data

Darren Winkler, DPM

Podiatrist · Torrington, CTNPI 1710966403

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 52.1% of the total.

$1,087in general payments, 2019–2025

Across 51 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$567
  • Organogenesis Inc.$199
  • GRT US Holding, Inc.$51
  • Kerecis Limited$51
  • Merck$40
  • KCI USA, Inc.$33
  • plus $146 from 8 others

What the payments were for

  • Food & beverage$1,087100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,087 in reported general payments places this provider in the 65th percentile of 119 podiatrist providers in Connecticut.

See all podiatrist providers in Connecticut

Medicare billing

Part B allowed, 2024
$109,894
Medicare patients
643
Services billed
2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox175$4,319
Lidocaine22$1,328
CiclopiroxCiclopirox Olamine41$991
Pregabalin20$505
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav38$428
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$423
Doxycycline Hyclate44$368
Clindamycin Hcl37$355
Ammonium Lactate24$300
Terbinafine Hcl38$289
Cephalexin38$280
Gabapentin25$267
Ketoconazole23$260
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$137
Mupirocin15$112

Paid to pharmacies, not to this prescriber.

Other podiatrist in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →